Cargando…

The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive loss of dopaminergic (DA) neurons in the substantia nigra. Although the exact cause of the dopaminergic neurodegeneration remains elusive, recent postmortem and experimental studies have revealed an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tufekci, Kemal Ugur, Genc, Sermin, Genc, Kursad
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034925/ https://www.ncbi.nlm.nih.gov/pubmed/21331154 http://dx.doi.org/10.4061/2011/487450

Ejemplares similares

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease
por: Tufekci, Kemal Ugur, et al.
Publicado: (2011)

MicroRNAs and Multiple Sclerosis
por: Tufekci, Kemal Ugur, et al.
Publicado: (2010)

Sulforaphane Inhibits Lipopolysaccharide-Induced Inflammation, Cytotoxicity, Oxidative Stress, and miR-155 Expression and Switches to Mox Phenotype through Activating Extracellular Signal-Regulated Kinase 1/2–Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Response Element Pathway in Murine Microglial Cells
por: Eren, Erden, et al.
Publicado: (2018)

Ethyl Pyruvate Attenuates Microglial NLRP3 Inflammasome Activation via Inhibition of HMGB1/NF-κB/miR-223 Signaling
por: Olcum, Melis, et al.
Publicado: (2021)

Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice
por: Tastan, Bora, et al.
Publicado: (2021)

Follow-up Analysis of Serum TNF-Related Apoptosis-Inducing Ligand Protein and mRNA Expression in Peripheral Blood Mononuclear Cells from Patients with Ischemic Stroke
por: Tufekci, Kemal Ugur, et al.
Publicado: (2018)

EPO Mediates Neurotrophic, Neuroprotective, Anti-Oxidant, and Anti-Apoptotic Effects via Downregulation of miR-451 and miR-885-5p in SH-SY5Y Neuron-Like Cells
por: Alural, Begum, et al.
Publicado: (2014)

Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway
por: Arioz, Burak I., et al.
Publicado: (2019)

Patient-Specific Pluripotent Stem Cells in Neurological Diseases
por: Durnaoglu, Serpen, et al.
Publicado: (2011)

The Adverse Effects of Air Pollution on the Nervous System
por: Genc, Sermin, et al.
Publicado: (2012)

Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells
por: Alural, Begum, et al.
Publicado: (2015)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
por: Arioz, Burak Ibrahim, et al.
Publicado: (2021)

Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
por: Tastan, Bora, et al.
Publicado: (2022)

Hypokinetic Dysarthria in Parkinson’s Disease: A Narrative Review
por: Atalar, Merve Sapmaz, et al.
Publicado: (2023)

Glycosphingolipids and neuroinflammation in Parkinson’s disease
por: Belarbi, Karim, et al.
Publicado: (2020)

Biomarker of Neuroinflammation in Parkinson’s Disease
por: Liu, Tsai-Wei, et al.
Publicado: (2022)

The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021)

Epigenetic Regulation of Neuroinflammation in Parkinson’s Disease
por: Rasheed, Madiha, et al.
Publicado: (2021)

Microglia Mediated Neuroinflammation in Parkinson’s Disease
por: Isik, Sevim, et al.
Publicado: (2023)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Neuroinflammation and Autophagy in Parkinson’s Disease—Novel Perspectives
por: Minchev, Danail, et al.
Publicado: (2022)

The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
por: Jurcau, Anamaria, et al.
Publicado: (2023)

Caregiver Burden and Quality of Life in Early and Late Stages of Idiopathic Parkinson’s Disease
por: Genç, Fatma, et al.
Publicado: (2019)

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
por: Zinger, Anna, et al.
Publicado: (2011)

Histone Deacetylase Inhibitor Trichostatin A Ameliorated Endotoxin-Induced Neuroinflammation and Cognitive Dysfunction
por: Hsing, Chung-Hsi, et al.
Publicado: (2015)

An algorithm for automated layout of process description maps drawn in SBGN
por: Genc, Begum, et al.
Publicado: (2016)

Neuroinflammation in Parkinson’s Disease and its Treatment Opportunities
por: Çınar, Elif, et al.
Publicado: (2022)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
por: Wang, Qinqin, et al.
Publicado: (2015)

The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
por: Heidari, Arash, et al.
Publicado: (2022)

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
por: Araújo, Bruna, et al.
Publicado: (2022)

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease
por: More, Sandeep Vasant, et al.
Publicado: (2013)

Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model
por: Huang, Chunxia, et al.
Publicado: (2018)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson’s Disease
por: Vallée, Alexandre, et al.
Publicado: (2020)

Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
por: Terkelsen, Miriam Højholt, et al.
Publicado: (2022)

Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023)

“Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease”
por: Rodríguez-Cruz, Alfredo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gvsdpc637g6asmkqdm114onrv3